Part 1 obgyn notes Sri Lanka
    NOTES for part 1
    /
    physiology
    /
    6.Baskaran Prostoglandins

    6.Baskaran Prostoglandins

    Owner
    U
    Untitled
    Verification
    Tags

    🧠 PART 1 — BIG PICTURE: STEROIDS vs PROSTAGLANDINS

    Core Concept

    Both are lipid hormones, but fundamentally different in:

    Feature
    Steroids
    Prostaglandins
    Substrate
    Cholesterol
    Arachidonic acid
    Enzymes
    CYP + HSD
    PLA2 + COX + PG synthases
    Receptors
    Intracellular nuclear receptors
    Cell surface GPCR
    Mechanism
    Genomic (DNA transcription)
    Second messenger
    Speed
    Slow (hours–days)
    Rapid (seconds–minutes)
    Action type
    Systemic endocrine
    Local paracrine/autocrine

    In pregnancy, these must coordinate precisely to regulate myometrial contraction timing.

    🧠 PART 2 — STEROID HORMONES

    2.1 Classification

    Steroids are divided into:

    • Corticosteroids → adrenal cortex
    • Gonadal steroids → ovary or testis

    All derived from cholesterol.

    2.2 Cholesterol Sources (4 Major)

    Steroidogenic cells obtain cholesterol from:

    1. De novo synthesis (from acetate)
    2. Plasma membrane
    3. Intracellular lipid droplets (cholesteryl esters)
    4. Plasma LDL cholesterol

    All must ultimately reach mitochondria.

    2.3 Rate-Limiting Step in Steroidogenesis

    Critical Reaction

    Cholesterol (27C) → Pregnenolone (21C)

    Enzyme:

    CYP11A1 (P450scc)

    Located in inner mitochondrial membrane facing matrix

    ⚠️ Important implication:

    Cholesterol must cross aqueous intermembrane space.

    2.4 Cholesterol Transport Machinery

    Requires:

    • StAR protein
    • Mitochondrial peripheral benzodiazepine receptor
    • Voltage-dependent anion channel activation → Cl⁻ efflux
    • Membrane apposition

    Hormones that increase StAR:

    • LH
    • FSH
    • hCG
    • ACTH

    2.5 Clinical Correlation — Lipoid Congenital Adrenal Hyperplasia

    Failure of StAR → no cholesterol entry into mitochondria

    Consequences:

    • Accumulation of cholesteryl esters in adrenal cortex
    • No corticosteroid synthesis
    • Usually lethal in utero
    • If born:
      • Poor lung inflation (no fetal glucocorticoids)
      • Salt-wasting crisis (no aldosterone)

    🧠 PART 3 — STEROIDOGENIC ENZYMES

    Two enzyme classes only:

    3.1 CYP Enzymes

    Functions:

    • Hydroxylation → increase solubility
    • Some act as lyases:
      • CYP11A1
      • CYP17A

    Mechanism:

    • Requires NADPH
    • Electron transfer via:
      • Ferredoxin reductase
      • Ferredoxin
      • To haem centre

    3.2 HSD Enzymes

    Types:

    • 3β-HSD
    • 17β-HSD

    Functions:

    • Oxidoreductases (short-chain alcohol dehydrogenases)
    • Modify alcohol/ketone groups

    3β-HSD

    • Converts:
      • Pregnenolone → Progesterone
      • DHEA → Androstenedione
    • Acts as Δ5 → Δ4 isomerase

    Double bond shifts:

    C5–6 → C4–5

    17β-HSD

    • Reduces C17 ketone
    • Converts:
      • Androstenedione → Testosterone
      • Estrone → Estradiol

    🧠 PART 4 — TISSUE-SPECIFIC STEROIDOGENESIS

    Pathway depends entirely on enzyme expression pattern.

    4.1 Testis Leydig Cells

    Enzymes:

    • CYP11A1
    • CYP17A
    • 3β-HSD
    • 17β-HSD

    Product:

    → Testosterone

    4.2 Ovarian Theca Cells

    Enzymes:

    • CYP11A1
    • CYP17A
    • 3β-HSD

    Product:

    → Androstenedione

    4.3 Ovarian Granulosa Cells

    FSH induces:

    • Aromatase (CYP19)

    Converts:

    Androstenedione → Estrone → Estradiol (via 17β-HSD)

    4.4 Corpus Luteum

    Expresses:

    • CYP11A1
    • 3β-HSD
    • CYP17A
    • CYP19
    • 17β-HSD

    Produces:

    • Progesterone
    • Estradiol

    🧠 PART 5 — PLACENTA AS “INCOMPLETE ENDOCRINE GLAND”

    Key missing enzyme:

    CYP17A

    Thus placenta cannot convert progestogens → androgens.

    Estrogen production requires:

    • Fetal adrenal gland
    • Maternal liver
    • Placenta

    Important fetal steroid:

    16α-hydroxyandrostenedione

    → Aromatised in placenta

    → Estriol

    Estriol = Marker of fetal adrenal function

    🧠 PART 6 — STEROID METABOLISM & CLEARANCE

    Peripheral metabolism:

    • Skin
    • Bone
    • Adipose tissue

    Examples:

    • Testosterone → DHT (5α-reductase 2) → genital virilisation
    • Testosterone → Estradiol (CYP19) → epiphyseal closure

    Clearance (Liver, 2-Step)

    Step 1:

    CYP or HSD create polar OH groups

    Step 2:

    Conjugation by:

    • Glucuronyltransferases
    • Sulphotransferases

    → Excretion in urine/faeces

    🧠 PART 7 — STEROID HORMONE ACTION

    7.1 Receptors

    Five steroid receptors exist.

    All share four domains:

    1. Ligand-binding domain
    2. DNA-binding domain (zinc fingers)
    3. Dimerisation domain
    4. Transactivation domains

    7.2 Mechanism

    Ligand binding →

    Receptor activation →

    Dimer formation (homo/hetero) →

    DNA binding at response elements →

    Recruit co-regulators

    7.3 Co-regulators

    Co-repressors

    • Recruit histone deacetylase
    • Condense DNA
    • Repress transcription

    Coactivators

    • Recruit histone acetyltransferase
    • Open chromatin
    • Increase transcription

    Speed

    Slow:

    6 hours → days

    Because genomic

    🧠 PART 8 — PROSTAGLANDINS

    8.1 Substrate: Arachidonic Acid

    Stored in membrane phospholipids.

    Liberated by:

    Phospholipase A2

    Inhibited by:

    Lipocortin

    (which is upregulated by glucocorticoids)

    8.2 COX Enzymes

    Arachidonate → PG G2 → PG H2

    Two forms:

    • COX-1 (constitutive)
    • COX-2 (inducible)

    Inhibited by:

    NSAIDs (indometacin, aspirin)

    8.3 Prostaglandin Synthases

    PGH2 → converted to:

    • PGD2
    • PGE2
    • PGF2α
    • PGI2 (prostacyclin)

    8.4 Inactivation

    15-hydroxyprostaglandin dehydrogenase

    Oxidises 15-OH → ketone

    Highly expressed in lungs

    → 65% inactivated per pulmonary pass

    Result:

    Short-lived, local action only

    🧠 PART 9 — PROSTAGLANDIN ACTION

    Despite lipid nature → act via:

    GPCR (cell surface)

    PGF2α

    Receptor:

    F-prostanoid receptor

    Pathway:

    PLC → IP3 → ↑Ca²⁺

    PGE2

    Four receptor subtypes

    Pathway:

    ↑ cAMP → activate PKA

    Opposing actions often due to different signalling.

    Speed:

    Seconds–minutes

    Acts via modifying pre-existing proteins.

    🧠 PART 10 — REGULATION OF MYOMETRIAL CONTRACTILITY

    Yin–Yang balance.

    10.1 Contractants

    • Oxytocin (originates from uterus, not posterior pituitary)
    • PGF2α

    Mechanism:

    Receptor → PLC → IP3 → ↑Ca²⁺

    Activates:

    • Myosin light chain kinase
    • Ca²⁺/calmodulin kinase

    Positive Feedback Loop

    Oxytocin → ↑ prostaglandins

    PGF2α → ↑ oxytocin receptors

    Amplification loop.

    Steroid Modulation

    Estradiol & Cortisol increase:

    • Oxytocin expression
    • Oxytocin receptor
    • F-prostanoid receptor
    • Prostaglandin enzymes

    10.2 Relaxants (Anticontractants)

    Work via:

    • cAMP
    • cGMP

    Cause:

    Dephosphorylation of myosin light chain

    Major Relaxant

    Progesterone

    Actions:

    • Decreases oxytocin synthesis
    • Decreases prostaglandin action
    • Increases cAMP
    • Decreases gap junction formation

    Uses both genomic + rapid non-genomic mechanisms.

    Other Relaxants

    • Nitric oxide (may act independent of cGMP)
    • Relaxin → ↑ cAMP
    • Prostacyclin → ↑ cAMP

    🧠 PART 11 — TERM LABOUR SWITCH

    At term:

    Placental progesterone output declines

    ↓ Progesterone : Estradiol ratio

    Shift:

    Relaxant dominance → Contractant dominance

    Labour begins.

    image
    image
    image
    image
    image
    image